RoTecPSMA

News

The UK has given a world-first approval to Rotop's RoTecPSMA, a new imaging agent for detecting lesions in men with prostate cancer.

News

Two players in the radiopharma sector, Curium and Lantheus, have agreed to merge and create an end-to-end player in diagnostics and therapeutics.

Digital

A new webinar from Konovo will address some of the critical topics impacting today’s healthcare market research industry.